Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
|
By LabMedica International staff writers Posted on 28 Jul 2015 |
In an oral poster presentation of the “Endocrinology in Preventive and Chronic Care” session at AACC 2015 (July 26-30; Atlanta, GA, USA), researchers presented and discussed results of a study suggesting that simple, noninvasive testing of hair samples may offer new insights into the relationship between asthma, levels of the stress-hormone cortisol, and related complications in pregnancy.
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Latest AACC 2015 News
- Automated Molecular Diagnostics System Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Blood Test Detects More High-Risk Prostate Cancers Than PSA
Prostate cancer is one of the most common malignancies in men, and screening often struggles to distinguish indolent tumors from clinically significant disease. Prostate-specific antigen (PSA) testing... Read more
Rapid Blood Test Aids Diagnosis of Acute Ischemic Stroke
Rapid and accurate differentiation of stroke types remains a persistent challenge in emergency medicine, particularly because early imaging can miss ischemic events that require time-sensitive intervention.... Read moreMolecular Diagnostics
view channel
Genomic Test Guides Taxane-Based Chemotherapy Selection in Breast Cancer
Selecting adjuvant chemotherapy for hormone receptor–positive, HER2-negative (HR+/HER2−) breast cancer remains challenging because current genomic assays mainly estimate recurrence risk rather than predict... Read more
RNA Blood Test May Enable Earlier Alzheimer’s Disease Diagnosis
Alzheimer’s disease affects an estimated 55 million people worldwide and remains difficult to diagnose at an early stage. Diagnostic workups can be complicated by symptom overlap with other conditions,... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Lab-on-a-Chip Approach Advances Immune–Cancer Cell Interaction Analysis
Conventional cytotoxicity assays often average responses across thousands of cells, obscuring how individual immune cells engage and kill tumor cells. For immunotherapy evaluation, the precise sequence... Read more
Antibody Profiles Provide Clues to Long COVID Severity and Symptoms
Persistent symptoms after acute COVID-19 affect millions of people, causing fatigue, respiratory issues, and cognitive deficits that can be difficult to quantify with standard tests. Clinical teams lack... Read moreMicrobiology
view channel
Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more
Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more
Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more
Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read morePathology
view channel
Study Highlights Biomarker Testing Delays in Lung Cancer Care
Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read more
Stain-Free Imaging Platform Matches Standard Cancer Pathology
Histopathology underpins cancer diagnosis, but turnaround times and inter-laboratory variability can limit timely, consistent interpretation. Conventional staining relies on chemical dyes and multiple... Read more
New Companion Diagnostic Expands Precision Medicine in Prostate Cancer
Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Partnership Aims to Improve Transplant Monitoring Across Care Continuum
Allograft rejection and chronic graft dysfunction remain major challenges in solid organ transplantation, requiring careful immunologic matching and long-term surveillance. Fragmented pre- and post-transplant... Read more
QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools
QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more









